In Conversation with Julie McCrossin AM

Presented by the GI Cancer Institute, In Conversation with Julie McCrossin AM is a series of short, thought-provoking bursts of discussion around and across the GI cancer experience – proudly featuring some of the best insights from the GI cancer community.

Madison ShakespeareDEEP LISTENING AND FIRST NATIONS CULTURAL SAFETY IN GI CANCER CLINICAL TRIALS
May 2, 2023
Gadigal Traditional Custodian Madison Shakespeare discusses the foundational role of cultural safety for First Nations patients and how… Read More
Madison ShakespeareFIRST NATIONS CULTURAL SAFETY AND PARTNERSHIP FOR GI CANCER CLINICAL TRIALS
May 2, 2023
Madison Shakespeare, Gadigal Traditional Custodian, shares why it is vital for any healthcare environment to treat… Read More
Madison ShakespeareFIRST NATIONS PEOPLES IN GI CANCER CLINICAL TRIALS
May 2, 2023
Madison Shakespeare shares insight on why inclusion of First Nations peoples in cancer clinical trials is essential, as… Read More
Christie Ah-FaPATIENT BARRIERS TO REPRESENTATION IN GI CANCER CLINICAL TRIALS
May 2, 2023
Christie Ah-Fa shares the barriers she and her late husband Lei experienced in his treatment of pancreatic cancer,… Read More
Christie Ah-FaCREATING BETTER EQUITY, DIVERSITY AND INCLUSION FOR PATIENTS IN GI CANCER CLINICAL TRIALS
May 2, 2023
Christie Ah-Fa suggests some practical actions to create a more equitable, diverse and inclusive environment for patients in… Read More
Prof Sabe SabesanWORKPLACE CULTURE FOR EQUITY OF ACCESS IN GI CANCER CLINICAL TRIALS
May 2, 2023
Prof Sabe Sabesan highlights the importance of workplace culture for healthcare professionals working in teleoncology. Read More
Prof Sabe SabesanTELETRIALS AND EQUITY OF ACCESS IN GI CANCER CLINICAL TRIALS
May 2, 2023
Prof Sabe Sabesan gives an overview of how the teletrial model works in oncological practice. Read More
Dr Abhi PalTHE NEED FOR DIVERSITY AND INCLUSIVITY IN GI CANCER CLINICAL TRIALS
May 2, 2023
Dr Abhi Pal unpacks three key reasons as to why the inclusion of culturally and linguistically diverse (CALD)… Read More
Dr Abhi PalWHAT CLINICIANS CAN DO FOR EQUITY, DIVERSITY AND INCLUSION IN GI CANCER TRIALS
May 2, 2023
Dr Abhi Pal lists three key things that clinicians can do now to make clinical trials more equitable,… Read More
Dr Abhi PalTHE NEED FOR BETTER ACCESS AND EQUITY IN GI CANCER CLINICAL TRIALS
May 2, 2023
Dr Abhi Pal spotlights the need for structural equity in clinical trials, so that a patient’s demographic does… Read More

Leave a Comment

Your email address will not be published. Required fields are marked *